Skip to main content

How a Popular Biotech ETF Fits Into the Coronavirus Investing Landscape

The coronavirus outbreak is prompting investors to visit the healthcare sector, a trend that could benefit ETFs, including the SPDR S&P Biotech ETF (NYSEArca: XBI). XBI, one of the largest biotechnology ETFs by assets, uses an equal-weight methodology, meaning it tilts toward smaller companies,...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.